000 01548 a2200433 4500
005 20250515164807.0
264 0 _c20090625
008 200906s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.01370-08
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCo, Edgie-Mark A
245 0 0 _aAssessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cJun 2009
300 _a2557-63 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntimalarials
_xpharmacology
650 0 4 _aArtemisinins
_xpharmacology
650 0 4 _aBenzothiazoles
650 0 4 _aChloroquine
_xpharmacology
650 0 4 _aDiamines
650 0 4 _aDrug Combinations
650 0 4 _aDrug Evaluation, Preclinical
_xmethods
650 0 4 _aDrug Interactions
650 0 4 _aFluorescent Dyes
650 0 4 _aHypoxanthine
_xmetabolism
650 0 4 _aMefloquine
_xpharmacology
650 0 4 _aOrganic Chemicals
650 0 4 _aParasitic Sensitivity Tests
_xmethods
650 0 4 _aPlasmodium falciparum
_xdrug effects
650 0 4 _aQuinolines
700 1 _aDennull, Richard A
700 1 _aReinbold, Drew D
700 1 _aWaters, Norman C
700 1 _aJohnson, Jacob D
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 53
_gno. 6
_gp. 2557-63
856 4 0 _uhttps://doi.org/10.1128/AAC.01370-08
_zAvailable from publisher's website
999 _c18784350
_d18784350